SHCBP1 drives tumor progression in triple-negative breast cancer

QR Code

SHCBP1 drives tumor progression in triple-negative breast cancer

BackgroundsTriple-negative breast cancer (TNBC) represents the most aggressive breast cancer subtype. The limited treatment options underscore the urgent need to explore novel molecular targets to combat TNBC progression. This study investigates the oncogenic functions of SHCBP1 in TNBC.Materials an...

Full description

Saved in:

Bibliographic Details
Main Authors:	Huiling Wang, Huijuan Dai, Liheng Zhou, Yanping Lin, Wenjin Yin, Jingsong Lu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Oncology
Subjects:	SHCBP1 single-cell RNA-seq triple negative breast cancer proliferation migration
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1587236/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Malic enzyme 2 promotes liver cancer progression by regulating SHCBP1
by: QIU Yuchong, DU Wenjing
Published: (2025-06-01)

MicroRNA-based potential diagnostic, prognostic and therapeutic applications in triple-negative breast cancer
by: Qian Tang, et al.
Published: (2019-12-01)

Blood mononuclear cell molecular landscape associated with tumor progression in triple-negative breast cancer
by: M. R. Patysheva, et al.
Published: (2023-11-01)

Triple – negative essential thrombocythemia in a child: A diagnostic challenge
by: Neha Goel, et al.
Published: (2025-06-01)

Tumor-derived exosomal lncRNA SNHG4 promotes triple-negative breast cancer progression by targeting XPO5
by: Zhi-Wen Wang, et al.
Published: (2025-06-01)

Results of combination treatment for triple-negative breast cancer
by: M. A. Sekundova, et al.
Published: (2014-07-01)

Role of Glucocorticoid Receptor in Triple-Negative Breast Cancer
by: Raj Kumar
Published: (2025-04-01)

In Silico Perspectives on Triple Negative Breast Cancer: Challenges and Progress
by: Maham Taqi, et al.
Published: (2025-06-01)

c-MYC Levels and Metabolic Parameters in Triple-Positive and Triple-Negative Breast Cancer
by: Doaa N. Abood, et al.
Published: (2025-06-01)

α9 Nicotinic Acetylcholine Receptor Promotes Tumor Proliferation and Suppresses Ferroptosis in Triple-Negative Breast Cancer
by: Xiaoli Feng, et al.
Published: (2025-06-01)

Diagnostic utility of ultrasound features in identifying triple-negative breast cancer
by: Jampana Sahitya, et al.
Published: (2025-05-01)

Caveolin-1 in Tumour Cells is Predominately Expressed in the Basal Subtype of Triple-Negative Breast Carcinoma
by: Savelina Popovska, et al.
Published: (2014-11-01)

Molecular genetic predictors of progression of triple negative breast cancer
by: I. S. Panchenko, et al.
Published: (2025-03-01)

IQGAP1 is a Specific Target of Haldol in Triple Negative Breast Cancer
by: Mahmood Meqdad
Published: (2025-06-01)

Nanoformulations Downregulating METTL16 Combined with mRNA Tumor Vaccines Suppress Triple-Negative Breast Cancer and Prevent Metastasis
by: Wang R, et al.
Published: (2025-07-01)

Translational drugs targeting cancer stem cells in triple-negative breast cancer
by: Felipe P. de Oliveira, et al.
Published: (2025-09-01)

TOMM40L promotes proliferation and migration of triple negative breast cancer cells and correlates with poor prognosis
by: ZHANG Ke, LU Jiangning, SUN Lixin, YU Long, SUN Lichao, RAN Yuliang
Published: (2025-05-01)

Omitting anthracyclines for the adjuvant treatment of patients with triple-negative breast cancer: A non-inferiority meta-analysis
by: Fabio Girardi, et al.
Published: (2025-10-01)

COMPARATIVE ANALYSIS OF DIFFERENT NEOADJUVANT CHEMOTHERAPY REGIMENS FOR TRIPLE-NEGATIVE BREAST CANCER
by: P. V. Krivorotko, et al.
Published: (2017-12-01)

Clinical case of torpid course of metastatic triple negative breast cancer
by: E. P. Kulikov, et al.
Published: (2022-03-01)

Chemoimmunomodulation in triple negative breast cancer: a key to maximizing anti-PD-1 chemoimmunotherapeutic efficacy
by: Mohammed O. Gbadamosi, et al.
Published: (2025-12-01)

The Role of Genomics and Transcriptomics in Characterizing and Predicting Patient Response to Treatment in Triple Negative Breast Cancer (TNBC)
by: Franklin Eduardo Corea-Dilbert, et al.
Published: (2025-04-01)

Size matters: a review of the challenges in and importance of multimodal approaches to the management of patients with small, node-negative, triple-negative breast cancer
by: Vishnu Prasath, et al.
Published: (2025-07-01)

USP44 promotes chemotherapeutic drug resistance of triple negative breast cancer through EZH2 protein stability
by: Pu Wu, et al.
Published: (2025-12-01)

Effect of body mass index on clinical and morphological characteristics of triple negative breast cancer
by: I. B. Schepotin, et al.
Published: (2014-07-01)

Case Report: Palliative Care for Metastatic triple negative Breast Cancer with Cutaneous Involvement
by: Kaylee Scarnati, et al.
Published: (2025-06-01)

Androgen receptor expression in triple negative breast cancer: an Algerian population study
by: Amel Hedjem, et al.
Published: (2025-12-01)

A Machine-Learning Model for the Prediction of Triple-Negative Breast Cancer Based on Multiparameter MRI
by: Cai Y, et al.
Published: (2025-07-01)

Network‐Based Integrative Analysis to Identify Key Genes and Corresponding Reporter Biomolecules for Triple‐Negative Breast Cancer
by: Pooja Singh, et al.
Published: (2025-05-01)

Novel Thymoquinone Derivative TQFL28 Inhibits Triple-Negative Breast Cancer (TNBC) Invasiveness In Vitro and In Vivo
by: Jiayue He, et al.
Published: (2025-06-01)

Neoadjuvant chemotherapy with or without metformin in early-stage or locally advanced (non-metastatic) triple negative breast cancer—an open-label phase 2 randomized controlled trial
by: Vinod K. Ramani, et al.
Published: (2025-06-01)

Potentiating Antibody-Dependent Cellular Cytotoxicity in Triple-Negative Breast Cancer via the Humanized Anti-CD147 Antibody
by: Kanyarat Thongheang, et al.
Published: (2025-04-01)

Biomimetic tumor cell membrane-camouflaged nanomicelles for synergistic chemo-immunotherapy of Triple-negative breast cancer
by: Xiaoman Xu, et al.
Published: (2025-08-01)

Multifactorial Analysis of Prognostic and Predictive Biomarkers in Triple Negative Breast Cancer Patients
by: V. N. Pavlov, et al.
Published: (2025-07-01)

Correction: Neoadjuvant chemotherapy with or without metformin in early-stage or locally advanced (non-metastatic) triple negative breast cancer—an open-label phase 2 randomized controlled trial
by: Vinod K. Ramani, et al.
Published: (2025-08-01)

Oral microbiome components predict response to neoadjuvant chemotherapy in triple-negative breast cancer patients
by: Xiaoyan Fu, et al.
Published: (2025-07-01)

The Association of Immune Cell Infiltration with Metastasis Location in De Novo Metastatic Triple Negative Breast Cancer: A Multicenter Cross-Sectional Study in Indonesia
by: Jeffry Beta Tenggara, et al.
Published: (2024-01-01)

GGT and GSH-triggered nanoplatform for efficient gambogic acid delivery and tumor penetration in triple-negative breast cancer
by: Su Li, et al.
Published: (2025-08-01)

Pathological complete response of locally advanced triple-negative breast cancer: case report
by: V. V. Konstantinova, et al.
Published: (2024-09-01)

Extracellular Vesicle Proteome Analysis Improves Diagnosis of Recurrence in Triple‐Negative Breast Cancer
by: Ju‐Yong Hyon, et al.
Published: (2025-06-01)